[1]
R. Bhaskar, M. Ola, and B. Patil, “Regulatory requirement for Pre & Post-approval management of Generic Drugs in US”, Int J Drug Reg Affairs, vol. 11, no. 2, pp. 94-109, Jun. 2023.